- “Teva Pharma recalls anti-anxiety drug Propofol” (Business Standard)
- “GSK gets EU clearance to buy Stiefel Laboratories” (Reuters)
- “Abbott Molecular sees diagnostic tests revolution” (Reuters)
- “Luminex Gets FDA Clearance for an Update to the xTAG Respiratory Viral Panel Package Insert” (Press release issued by Luminex Corp., Trading Markets)
- “Baxter can take no more H1N1 flu vaccine orders” (Reuters)
- “Gilead, J&J to develop once-daily HIV pill” (Reuters)
- “Watson confirms filing of ANDA for generic bladder drug” (Trading Markets)
- “Actelion moves heart,lung drug to late stage study” (Reuters)
- “Earnings Preview: Schering-Plough to report 2Q” (Forbes)
- “BSI-201 Enters Phase 3 in Metastatic Triple Negative Breast Cancer” (Press release issued by Sanofi-Aventis, Trading Markets)
- “Alnylam Announces Extension of RNAi Therapeutics Collaboration with Novartis” (Press release issued by Alnylam Pharmaceuticals, Inc., BusinessWire)
THE LATEST WORD
Top Industry Stories – July 17, 2009
Posted on July 17th, 2009 | by Rxmedyn | No Comments »Posted in Industry Stories
SUBSCRIBE-
Recent Posts
Archives
- February 2012
- January 2012
- December 2011
- November 2011
- October 2011
- September 2011
- May 2011
- April 2011
- March 2011
- February 2011
- January 2011
- December 2010
- November 2010
- October 2010
- September 2010
- August 2010
- July 2010
- June 2010
- May 2010
- April 2010
- March 2010
- February 2010
- January 2010
- December 2009
- November 2009
- October 2009
- September 2009
- August 2009
- July 2009
- June 2009
- May 2009
Careers | © 2009 Medical Dynamics